Skip to content

The relationship between postoperative delirium and aneasthetic depth in elderly patients and the study on markers of postoperative delirium

The relationship between postoperative delirium and aneasthetic depth in elderly patients and the study on markers of postoperative delirium

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000032663
Enrollment
Unknown
Registered
2020-05-05
Start date
2020-05-18
Completion date
Unknown
Last updated
2020-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative delirium

Interventions

Deep anesthesia group:sevoflurane aneasthesia, BIS=35
Light aneasthesia group:sevoflurane aneasthesia, BIS=50

Sponsors

Department of Anesthesiology, Huashan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) Aged between 65 and 90 years; (2) Patients with gastrointestinal tumors expected for elective surgery under sevoflurane general anesthesia (2h-6h); (3) ASA Physical Status Classification I-III; (4) Agree to participate in the study voluntarily, and sign the written informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients with preoperative history of schizophrenia, and/or taking typical and atypical antipsychotic drugs; (2) Patients with preoperative cognitive dysfunction based on MMSE scale; (3) Severe functional impairment of hearing, vision, and language system; (4) Critically ill, severe renal dysfunction (requiring of renal replacement therapy), severe hepatic dysfunction (Child-Pugh classification C); (5) Patients planning to enter the ICU after surgery; (6) Patients with difficult airway that require awake intubation or have been diagnosed with moderate to severe OSAS; (7) Forehead infections or allergies that not suitable for EEG electrode placement; (8) Patients with allergies or contraindications to conventional anesthetics; (9) Patients participating in other clinical studies at the same time.

Design outcomes

Primary

MeasureTime frame
Incidence of delirium within the first 5 postoperative days;blood biomarkers for POD;EEG features for POD;

Secondary

MeasureTime frame
postoperative sleep quality;postoperative recovery quality;Length of postoperative hospital stay;Hospital mortality;30-day postoperative mortality;the relationship between EEG changes and POD incidence;

Countries

China

Contacts

Public ContactYingwei Wang, Yelin Wang

Huashan Hospital, Fudan University

boning1029@163.com+86 13918690528

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026